INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 147 filers reported holding INSYS THERAPEUTICS INC NEW in Q3 2015. The put-call ratio across all filers is 2.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $15,775,000 | -13.8% | 1,714,727 | +10.5% | 0.00% | -25.0% |
Q3 2016 | $18,301,000 | -4.4% | 1,552,250 | +5.0% | 0.00% | 0.0% |
Q2 2016 | $19,135,000 | -20.2% | 1,478,755 | -1.3% | 0.00% | -33.3% |
Q1 2016 | $23,967,000 | -40.9% | 1,498,868 | +5.9% | 0.01% | -33.3% |
Q4 2015 | $40,535,000 | -10.2% | 1,415,828 | -10.7% | 0.01% | -25.0% |
Q3 2015 | $45,118,000 | -15.4% | 1,585,310 | +6.7% | 0.01% | -7.7% |
Q2 2015 | $53,353,000 | +28.0% | 1,485,339 | +107.1% | 0.01% | +30.0% |
Q1 2015 | $41,691,000 | +42.3% | 717,195 | +3.2% | 0.01% | +42.9% |
Q4 2014 | $29,305,000 | +14.5% | 695,087 | +5.3% | 0.01% | 0.0% |
Q3 2014 | $25,601,000 | +26.1% | 660,160 | +1.5% | 0.01% | +16.7% |
Q2 2014 | $20,310,000 | -18.9% | 650,326 | +7.6% | 0.01% | -14.3% |
Q1 2014 | $25,046,000 | +67.8% | 604,540 | +56.8% | 0.01% | +40.0% |
Q4 2013 | $14,923,000 | +194.2% | 385,516 | +166.0% | 0.01% | +150.0% |
Q3 2013 | $5,072,000 | +190.3% | 144,942 | +14.9% | 0.00% | +100.0% |
Q2 2013 | $1,747,000 | – | 126,195 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Orbimed Advisors | 6,171,440 | $54,802,000 | 0.52% |
Regal Investment Advisors LLC | 161,600 | $1,435,000 | 0.34% |
Folger Hill Asset Management LP | 396,315 | $3,519,000 | 0.30% |
SCHNEIDER CAPITAL MANAGEMENT CORP | 181,900 | $1,615,000 | 0.29% |
Mirae Asset Global Investments Co., Ltd. | 1,033,683 | $9,179,000 | 0.17% |
JW Asset Management, LLC | 29,409 | $72,000 | 0.05% |
TCI Wealth Advisors, Inc. | 9,516 | $85,000 | 0.04% |
GAM Holding AG | 83,940 | $745,000 | 0.03% |
Freedom Investment Management, Inc. | 63,032 | $560,000 | 0.03% |
Sterling Investment Advisors, Ltd. | 5,000 | $44,000 | 0.03% |